Vitebsk Biopharma Factory increased its net profit by 9 times thanks to the implementation of an innovative project

June 30, Vitebsk / Diana Kurilo - BELTA /. Private unitary enterprise "Vitebsk Biopharma" increased its net profit by 9 times to Br1.5 billion in January-May of the current year compared to the same period last year, the enterprise informed a BELTA correspondent. The profit growth was ensured by the implementation of the innovative project "Expansion of UP Vitebsk Biopharma", which is carried out according to the state program for the development of veterinary drug production. In accordance with the project, it is planned to complete the construction of the main production building of the enterprise with a total area of 18.7 thousand sq.m and equip new production facilities with modern technological equipment that meets GMP requirements. State investments in the project from 2005 to 2010 amounted to Br191.1 billion. At this stage, a commission is working at the enterprise to commission the second and third start-up complexes, which will produce finished dosage forms, bacterial vaccines and infusion solutions for veterinary medicine, as well as establish the production of import-substituting viral vaccines. The factory was founded in 1930 and specializes in veterinary therapeutic and diagnostic drugs for animal husbandry. In January-May of the current year, the production volume of products at comparable prices amounted to Br6 billion, which is 26% more than in the same period last year. The growth rate of new products in January-May was 217.6% and is estimated at Br1.5 billion. The volume of shipped products at current prices for five months reached Br5 billion, which is 28% higher than the same indicators last year. The enterprise exports products to Azerbaijan, Turkey, Kazakhstan. Today, the enterprise expects Prime Minister of Belarus Sergei Sidorsky on a working visit. -0-